Clinical Trial

Intra-arterial Hypothermic Magnesium Sulfate Infusion in Combination with Endovascular Thrombectomy in Acute Ischemic Stroke

Study acronym: Hypo-Mag
Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 7, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of this study is to estimate the safety of intra-arterial hypothermic magnesium sulfate infusion after endovascular thrombectomy in patients with acute ischemic stroke
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-03.
Trial Details
NCT Number NCT06760195
Lead Sponsor Capital Medical University
Conditions Acute Ischemic Stroke
Enrollment 6 participants
Start Date 2025-01-10
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-07